Director/PDMR Shareholding

RNS Number : 9328H

Deltex Medical Group PLC

13 June 2017

 

13 June 2017

Deltex Medical Group plc

Director/PDMR Shareholding

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), announces that it has received notification that on 12 June 2017 its Chairman, Nigel Keen, transferred 1,996,186 Ordinary Shares into The Imperialise Limited Pension Fund at a price of 4.0p per Ordinary Share. Nigel Keen is the principal beneficiary of this fund and following this transaction his beneficial interest remains 26,193,780 Ordinary Shares in the Company representing 8.82% of the total issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

The following notifications are made in accordance with Article 19 of the EU Market Abuse Regulation

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Nigel Keen
2	Reason for the notification
a)	Position/status	Chairman
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Deltex Medical Group plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1p each in Deltex Medical Group plc Identification code (ISIN) for Deltex Medical Group plc ordinary shares: GB0059337583
b)	Nature of the transaction	Transfer of shares into The Imperialise Limited Pension Fund.
c)	Price(s) and volume(s)	Price(s) Volume(s) 4.0p 1,996,186
d)	Aggregated information - Aggregated volume - Price	1,996,186 4.0p
e)	Date of the transaction	12 June 2017
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

For further information, please contact:-

Deltex Medical Group plc	01243 774 837 [e-mail]
Nigel Keen, Chairman
Ewan Phillips, Chief Executive Jonathan D Shaw, Finance Director
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie Ciaran Walsh
Financial Public Relations
IFC Advisory	0203 053 8671
Tim Metcalfe Graham Herring Heather Armstrong

 

END

 

 

DSHLIFFTRVIVLID